Document is current

Article History

Received: 5 June 2024

Accepted: 22 July 2024

First Online: 7 August 2024

Conflict of Interest

: Takahisa Hirose received research funds from Nippon Boehringer Ingelheim Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Sumitomo Pharma Co., Ltd. and lecture fees from Sanofi K.K., Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd., MSD K.K., Abbott Medical Japan LLC, and Sumitomo Pharma Co., Ltd. None of the funding agencies played a role in the study design, data collection and analysis, decision to publish, or manuscript preparation. Genki Sato and Hiroshi Uchino declare no conflicts of interest.

: All procedures performed in this study were in accordance with the Declaration of Helsinki as revised in 2013. The Ethics Committee of Toho University Omori Medical Center, Tokyo, Japan, approved all procedures performed in this study (No. M23185 23052). This study used retrospective non-identifiable data obtained by the treating physicians; therefore, on the basis of the decision of the local Ethics Committee of Toho University Omori Medical Center, informed consent was not required. Patients had the opportunity to object to using their data for retrospective scientific research; however, none objected.